These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1948740)

  • 1. [The morphological aspects of nephrotic hyperlipidemia].
    Neverov NI; Ivanov AA; Severgina ES; Nikitina EA; Tambovtseva EV; Tareeva IE
    Ter Arkh; 1991; 63(6):33-7. PubMed ID: 1948740
    [No Abstract]   [Full Text] [Related]  

  • 2. [The morphological characteristics of the nephrotic form of glomerulonephritis in children at puberty].
    Romanenko AM; Pyrig LA; Bagdasarova IV; Emel'ianova OV; Antonovich TM
    Arkh Patol; 1993; 55(3):9-13. PubMed ID: 7944982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperlipoproteinemia as a factor in the progression of glomerulonephritis with nephrotic syndrome].
    Smirnov AV; Sazonets GI; Rakitianskaia IA; Travkina ES
    Ter Arkh; 1992; 64(11):45-8. PubMed ID: 1293843
    [No Abstract]   [Full Text] [Related]  

  • 4. [Morphological characteristics of chronic glomerulonephritis with the nephrotic variant of the disease course].
    Taran EI
    Vrach Delo; 1987 Jul; (7):67-70. PubMed ID: 3630127
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and morphological characteristics of membranous, proliferative glomerulonephritis].
    Riabov SI; Klemina IK; Plotkin VIa
    Klin Med (Mosk); 1980 Sep; 58(9):46-51. PubMed ID: 7412193
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of biopsy an partial kidney function data in chronic glomerulonephritis].
    Ratner NA; Vikhert AM; Kramer AA; aĭkova DA; Kul'dova SKh
    Klin Med (Mosk); 1970 Jul; 48(7):25-33. PubMed ID: 5494090
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current state of the problem of lipid metabolism in patients with kidney diseases].
    Storozhenko AA
    Klin Med (Mosk); 1973 Oct; 51(10):28-30. PubMed ID: 4787276
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nephrotic syndrome (clinico-morphological, immunological and biochemical aspects)].
    Riabov SI; Kozlov VV; Kozhevnikov AD; Rakitianskaia IA; Smirnov AV
    Ter Arkh; 1988; 60(6):24-8. PubMed ID: 3206362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The nephrotic syndrome caused by minimal lesions nephropathy and focal glomerulosclerosis. Morphological and clinical aspects].
    Barbiano Di Belgiojoso G; Bertoli S; Busnach G; Casanova S; Dal Col A; Confalonieri R; Galato R; Micoli G; Surian M; Minetti L
    Minerva Nefrol; 1981; 28(3):403-14. PubMed ID: 7329618
    [No Abstract]   [Full Text] [Related]  

  • 10. [Morphological bases of the nephrotic syndrome in chronic glomerulonephritis].
    Sokolova RI; Vikhert AM; Kozdoba OA
    Arkh Patol; 1973; 35(5):47-53. PubMed ID: 4124110
    [No Abstract]   [Full Text] [Related]  

  • 11. [Focal segmental glomerulosclerosis].
    Plotkin VIa; Klemina IK
    Klin Med (Mosk); 1985 Jan; 63(1):86-91. PubMed ID: 3990195
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperlipidemia of the nephrotic syndrome.
    Kaysen GA
    Kidney Int Suppl; 1991 Apr; 31():S8-15. PubMed ID: 2046275
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nephrotic syndrome in primary glomerulonephritis].
    Riabov SI; Plotkin VIa; Klemina IK
    Ter Arkh; 1986; 58(8):65-71. PubMed ID: 3764764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological study of nephrotic syndrome in adults.
    Shanbhag VV; Purandare SM; Sundaram P
    J Postgrad Med; 1973 Jan; 19(1):1-8. PubMed ID: 4792962
    [No Abstract]   [Full Text] [Related]  

  • 15. [The catamnestic assessment of the efficacy of combined pathogenetic therapy in patients with different clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa; Serov VV; Varshavskiĭ VA; Biriukova LS; Stenina II
    Ter Arkh; 1990; 62(6):42-6. PubMed ID: 2218925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent trends in the therapy of hyperlipidemia in nephrotic syndrome].
    Campanacci L; Guarnieri GF; Faccini L; Bellini G; Gambari PF
    G Clin Med; 1973 Oct; 54(10):714-33. PubMed ID: 4789301
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biomicroscopy of the anterior eye segment in chronic renal insufficiency].
    Szmigielski M; Gradowska L; Komitowski D
    Klin Oczna; 1969; 39(5):679-82. PubMed ID: 5357265
    [No Abstract]   [Full Text] [Related]  

  • 18. Nephrotic syndrome in Zaire. Morphological and aetiological aspects.
    Pakasa M; Kalengayi MR
    Tropenmed Parasitol; 1984 Sep; 35(3):193-5. PubMed ID: 6495388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinico-morphological dynamics of membranoproliferative glomerulonephritis].
    Shishkin AN; Komandenko MS; Shevchenko SM
    Vrach Delo; 1987 Mar; (3):84-6. PubMed ID: 3590710
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nephrotic hyperlipidemia and its clinical significance].
    Neverov NI; Srinivas KV
    Ter Arkh; 1990; 62(6):150-3. PubMed ID: 2218917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.